Nuzenio

Expanded Prostate Cancer

Expanded Prostate Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 04:00:00 GMTFDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer Center
Wed, 05 Aug 2026 19:13:14 GMTCADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data - Stocktwits
Mon, 03 Aug 2026 21:53:12 GMTCorrection to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 - marketscreener.com
Mon, 03 Aug 2026 15:26:00 GMTFDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints News
Sat, 01 Aug 2026 13:16:50 GMTFDA Expands Approval of Pluvicto in Combination with ARPI for PSMA-Positive mAPMN/S Prostate Cancer - diagnosticimaging.com
Fri, 31 Jul 2026 21:06:00 GMTNovartis Wins FDA Approval for Expanded Prostate Cancer Treatment For Pluvicto - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Expanded Prostate Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.